Hood River Capital Management’s bluebird bio BLUE Stock Holding History

Hood River Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-9,193	Closed	-$8.07M	–	95
2016 Q3	$8.07M	Buy	+9,193	New	+$6.66M	0.83%	53
2015 Q3	–	Sell	-4,545	Closed	-$9.91M	–	95
2015 Q2	$9.91M	Sell	4,545 -11	-0.2%	-$22.4K	1.21%	37
2015 Q1	$7.13M	Sell	4,556 -192	-4%	-$253K	0.88%	53
2014 Q4	$5.64M	Buy	+4,748	New	+$3.17M	0.71%	61

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Hood River Capital Management's BLUE Position: Q4 2016 in Review

Hood River Capital Management sold out of bluebird bio (BLUE) in Q4 2016, closing a stake of 9,193 shares — an estimated $8.07M sold.

Hood River Capital Management first reported a position in BLUE in Q4 2014 and held it in 4 quarters. The position peaked at $9.91M in Q2 2015. 199 funds tracked by Wall St. Rank hold BLUE as of Q4 2016.

Hood River Capital Management reported no remaining bluebird bio position as of Q4 2016 after selling out during the quarter.
Hood River Capital Management sold 9,193 bluebird bio shares in Q4 2016, an estimated $8.07M.
Hood River Capital Management first reported a position in bluebird bio in Q4 2014 and held it in 4 quarters.
Hood River Capital Management's bluebird bio position peaked at $9.91M in Q2 2015.
199 funds tracked by Wall St. Rank held bluebird bio as of Q4 2016.

Based on Hood River Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.